Form 4: Hologic Director Madaus Acquires 3,190 Restricted Stock Units

Hologic Inc. Director Martin D. Madaus acquired 3,190 restricted stock units, vesting at the 2027 Annual Meeting of Stockholders.

Summary

• Director Martin D. Madaus acquired 3,190 restricted stock units (RSUs) of Hologic Inc. common stock on February 26, 2026.
• These RSUs are scheduled to vest on the date of the 2027 Annual Meeting of Stockholders.
• The restricted stock units will be settled in shares of common stock on a one-for-one basis upon vesting.
• Following this transaction, Mr. Madaus directly holds 5,396 shares and indirectly holds 5,445 shares through a revocable trust.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as the acquisition of restricted stock units by a director indicates continued alignment of management's interests with the company's long-term performance and shareholder value.

Positives

• Director Madaus's acquisition of 3,190 restricted stock units aligns his interests with long-term shareholder value.

Future Outlook

The restricted stock units are scheduled to vest on the date of the 2027 Annual Meeting of Stockholders, indicating a future equity payout for the director.

Industry Context

StockSavvy.ai notes that insider acquisitions, particularly of restricted stock units, are a common form of executive compensation designed to align management incentives with long-term company performance and shareholder interests within the medical technology sector.

Comparison to Industry Standards

• StockSavvy.ai observes that granting restricted stock units to directors is a standard practice in many industries, including medical technology, to incentivize long-term commitment and performance. This aligns with compensation structures seen at comparable companies like Intuitive Surgical (ISRG) or Stryker Corporation (SYK), where equity awards are a significant component of executive and director remuneration.

Related Party Transactions

• The acquisition of restricted stock units by Director Martin D. Madaus represents a related party transaction as part of his compensation.

Stakeholder Impact

• Shareholders: The acquisition of RSUs by a director can be seen as a positive signal of management's commitment to long-term value creation, potentially fostering shareholder confidence.

Next Steps

• The restricted stock units will vest on the date of the 2027 Annual Meeting of Stockholders.

Key Dates

Recommendation

The acquisition of restricted stock units by a director, while a form of compensation, generally indicates continued confidence in the company's future and aligns management's interests with long-term shareholder value. This reinforces a 'hold' position for existing investors, suggesting stability rather than an immediate catalyst for significant price movement.

Keywords

Hologic, HOLX, Insider Trading, Form 4, Restricted Stock Units, Director Acquisition, Equity Compensation